Aspire Fertility-Dallas

Addison, Texas 75001

Medical Director: Christine Mansfield, MD

Located in Addison, Texas, Aspire Fertility-Dallas offers comprehensive reproductive care under the guidance of Medical Director Christine Mansfield, MD. The clinic provides a full range of fertility services, including IVF, egg freezing, donor egg programs, and surrogacy coordination. With their verified lab accreditation, you can trust that your treatment is supported by high-quality laboratory standards.

Understanding that choosing a fertility clinic can feel overwhelming, the numbers may help provide clarity about what to expect. For patients under 35, Aspire Fertility-Dallas reports a live birth rate of 42.10% per cycle, while patients ages 35-37 see a 29.70% live birth rate. In 2022, the clinic completed 818 treatment cycles, reflecting their experience in helping families grow. These statistics represent real outcomes for real families, and while every journey is unique, they offer insight into the clinic's track record. The team at Aspire Fertility-Dallas is committed to providing personalized care as you navigate your fertility journey.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3542.10%-6.334.90%48.4%
35–3729.70%-6.332.80%36%
38–4030.90%+7.347.20%23.6%
Over 407.10%-2.4Not reported9.5%

Based on 818 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.